In the present study, RCAN2 was identified as a harmful predictor; however, our results are the contrary to the finding of Niitsu et al. (Niitsu et al., 2016) This may be related to the KRAS mutation in CRC leading to the decreased expression of RCAN2. The gene discussed is KRAS; the disease is colorectal carcinoma.